Why is Titan Biotech falling/rising?

As of 31-Jul, Titan Biotech Ltd is experiencing a decline in its stock price, currently at Rs 427.05, reflecting a decrease of Rs 6.9 or 1.59%. The stock has been underperforming, having lost 5.3% over the last six days, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock's delivery volume has significantly decreased by 46.75% compared to the 5-day average, indicating falling investor participation. The company has also reported negative results for the last three consecutive quarters, contributing to a poor long-term growth outlook, with net sales and operating profit growth rates of only 14.52% and 12.73% respectively over the past five years.
In the broader market context, Titan Biotech's performance has been notably weaker than the benchmark, with a one-week return of -4.80% compared to the Sensex's -1.22%. Over the past year, the stock has generated a return of -25.99%, significantly underperforming the market, which saw a decline of only -3.20%. This stark contrast highlights the challenges faced by Titan Biotech, including its high valuation relative to peers and declining profitability, which have led to a negative sentiment among investors.